Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 10 de 10
Filter
1.
Transplantation ; 101(4): 811-820, 2017 04.
Article in English | MEDLINE | ID: mdl-28009779

ABSTRACT

BACKGROUND: Carbapenem-resistant Enterobacteriaceae (CRE) is an emergent microorganism of infections after liver transplant (LT). The aim of this study was to analyze the risk factors for CRE acquisition and infection after LT. METHODS: This was a prospective cohort study involving patients who underwent LT in the 2010 to 2014 period. Surveillance cultures for CRE were collected immediately before LT and weekly thereafter until hospital discharge. RESULTS: We analyzed 386 patients undergoing a total of 407 LTs. Before LT, 68 (17.6%) patients tested positive for CRE, 11 (16.2%) of those patients having CRE infection, whereas 119 (30.8%) patients acquired CRE after LT. Post-LT CRE infection was identified in 59 (15.7%) patients: Klebsiella pneumoniae was isolated in 83.2%; surgical site infection was the most common type of infection (46.7%). Multivariate analysis showed that post-LT dialysis was the only risk factor for post-LT CRE acquisition. Eighty-two percent of patients who underwent 3 or more post-LT dialysis sessions and acquired CRE before LT evolved with post-LT CRE infection. Other risk factors for CRE infection were acquisition of CRE post-LT, Model for End-Stage Liver Disease score greater than 32, combined transplantation, and reoperation. Patients who acquired CRE before LT had a high risk of developing CRE infection (P < 0.001). CONCLUSIONS: Measures for minimizing that risk, including altering the antibiotic prophylaxis, should be investigated and implemented.


Subject(s)
Carbapenems/therapeutic use , Drug Resistance, Bacterial , Enterobacteriaceae Infections/drug therapy , Liver Transplantation , Transplant Recipients , Adolescent , Adult , Aged , Chi-Square Distribution , Enterobacteriaceae Infections/diagnosis , Enterobacteriaceae Infections/microbiology , Enterobacteriaceae Infections/mortality , Female , Humans , Liver Transplantation/adverse effects , Liver Transplantation/mortality , Logistic Models , Male , Middle Aged , Multivariate Analysis , Odds Ratio , Proportional Hazards Models , Prospective Studies , Renal Dialysis/adverse effects , Risk Assessment , Risk Factors , Surgical Wound Infection/diagnosis , Surgical Wound Infection/drug therapy , Surgical Wound Infection/microbiology , Time Factors , Treatment Outcome , Young Adult
2.
J Microbiol Methods ; 123: 39-43, 2016 Apr.
Article in English | MEDLINE | ID: mdl-26844885

ABSTRACT

Fusarium is a waterborne fungus that causes severe infections especially in patients with prolonged neutropenia. Traditionally, the detection of Fusarium in water is done by culturing which is difficult and time consuming. A faster method is necessary to prevent exposure of susceptible patients to contaminated water. The objective of this study was to develop a molecular technique for direct detection of Fusarium in water. A direct DNA extraction method from water was developed and coupled to a genus-specific PCR, to detect 3 species of Fusarium (verticillioides, oxysporum and solani). The detection limits were 10 cells/L and 1 cell/L for the molecular and culture methods, respectively. To our knowledge, this is the first method developed to detect Fusarium directly from water.


Subject(s)
Fresh Water/microbiology , Fusarium/isolation & purification , Polymerase Chain Reaction/methods , DNA Primers/genetics , DNA, Fungal/genetics , Fusarium/genetics
3.
Clin Microbiol Infect ; 21(3): 268.e1-7, 2015 Mar.
Article in English | MEDLINE | ID: mdl-25658562

ABSTRACT

Fusarium is considered an emerging pathogen, and there are few reports of fusariosis in children. The objective of this study was to describe an outbreak of invasive fusariosis in a children's cancer hospital. A neutropenic 17-year-old male patient hospitalized for 10 days for a relapse of acute myeloid leukaemia, under chemotherapy, presented fever without any other symptoms; a thoracic computerized tomography showed bilateral pulmonary nodules. During voriconazole treatment, 1-cm reddened and painful subcutaneous nodules appeared on arms and legs and the culture of a skin biopsy revealed F. solani. Another case occurred 11 days later and started an outbreak investigation. Water samples for cultures were collected from taps, showers and water reservoirs. Air from all patient rooms was sampled. Faucets and the drains of sinks and showers were swabbed and cultured. Environmental and clinical isolates were typed. There were 10 confirmed cases of infection caused by Fusarium spp. F. oxysporum and F. solani were isolated from water, swabs and air in patient rooms. Many control measures were instituted, but the outbreak was only controlled 1 year after the first case, when water filters filtering 0.2 µm were installed at the exit of all faucets and showers in all patient rooms (points-of-use). Typing demonstrated that clinical isolates of F. oxysporum were similar to those of the environment. In conclusion, to our knowledge this is the first reported outbreak of invasive fusariosis in children with oncohaematologic disease. It was controlled using 0.2-µm filters in all tap faucets and showers.


Subject(s)
Cancer Care Facilities , Cross Infection , Disease Outbreaks , Fusariosis/epidemiology , Fusariosis/microbiology , Fusarium/isolation & purification , Hospitals, Pediatric , Adolescent , Child , Female , Fusariosis/diagnosis , Fusarium/classification , Fusarium/genetics , Humans , Leukemia, Myeloid, Acute/complications , Leukemia, Myeloid, Acute/therapy , Male , Molecular Typing , Opportunistic Infections/epidemiology , Opportunistic Infections/microbiology , Phylogeny
4.
PLoS One ; 9(9): e108453, 2014.
Article in English | MEDLINE | ID: mdl-25255079

ABSTRACT

The objectives of this study were to develop a rat model of gastrointestinal colonization with vancomycin-resistant Enterococcus faecalis (VRE) and extended-spectrum beta-lactamase (ESBL)-producing E. coli and to evaluate intestinal translocation to blood and tissues after total and partial hepatic ischemia. Methods - We developed a model of rat colonization with VRE and ESBL-E coli. Then we studied four groups of colonized rats: Group I (with hepatic pedicle occlusion causing complete liver ischemia and intestinal stasis); Group II (with partial liver ischemia without intestinal stasis); Group III (surgical manipulation without hepatic ischemia or intestinal stasis); Group IV (anesthetized without surgical manipulation). After sacrifice, portal and systemic blood, large intestine, small intestine, spleen, liver, lungs, and cervical and mesenteric lymph nodes were cultured. Endotoxin concentrations in portal and systemic blood were determined. Results - The best inocula were: VRE: 2.4×10(10) cfu and ESBL-E. coli: 1.12×10(10) cfu. The best results occurred 24 hours after inoculation and antibiotic doses of 750 µg/mL of water for vancomycin and 2.1 mg/mL for ceftriaxone. There was a significantly higher proportion of positive cultures for ESBL-E. coli in the lungs in Groups I, II and III when compared with Group IV (67%; 60%; 75% and 13%, respectively; p:0.04). VRE growth was more frequent in mesenteric lymph nodes for Groups I (67%) and III (38%) than for Groups II (13%) and IV (none) (p:0.002). LPS was significantly higher in systemic blood of Group I (9.761 ± 13.804 EU/mL-p:0.01). No differences for endotoxin occurred in portal blood. Conclusion -We developed a model of rats colonized with resistant bacteria useful to study intestinal translocation. Translocation occurred in surgical procedures with and without hepatic ischemia-reperfusion and probably occurred via the bloodstream. Translocation was probably lymphatic in the ischemia-reperfusion groups. Systemic blood endotoxin levels were higher in the group with complete hepatic ischemia.


Subject(s)
Bacterial Translocation , Enterococcus faecalis/drug effects , Escherichia coli/genetics , Gram-Positive Bacterial Infections/complications , Gram-Positive Bacterial Infections/microbiology , Liver/microbiology , Liver/pathology , Reperfusion Injury/complications , Animals , Bacteremia , Disease Models, Animal , Endotoxemia , Male , Rats , Vancomycin/pharmacology , Vancomycin Resistance , beta-Lactamases/genetics
5.
BMC Infect Dis ; 12: 358, 2012 Dec 18.
Article in English | MEDLINE | ID: mdl-23249441

ABSTRACT

BACKGROUND: Treatment of chronically infected wounds is a challenge, and bacterial environmental contamination is a growing issue in infection control. Ozone may have a role in these situations. The objective of this study was to determine whether a low dose of gaseous ozone/oxygen mixture eliminates pathogenic bacteria cultivated in Petri dishes. METHODS: A pilot study with 6 bacterial strains was made using different concentrations of ozone in an ozone-oxygen mixture to determine a minimally effective dose that completely eliminated bacterial growth. The small and apparently bactericidal gaseous dose of 20 µg/mL ozone/oxygen (1:99) mixture, applied for 5 min under atmospheric pressure was selected. In the 2nd phase, eight bacterial strains with well characterized resistance patterns were evaluated in vitro using agar-blood in adapted Petri dishes (105 bacteria/dish). The cultures were divided into 3 groups: 1--ozone-oxygen gaseous mixture containing 20 µg of O(3)/mL for 5 min; 2--100% oxygen for 5 min; 3--baseline: no gas was used. RESULTS: The selected ozone dose was applied to the following eight strains: Escherichia coli, oxacillin-resistant Staphylococcus aureus, oxacillin-susceptible Staphylococcus aureus, vancomycin-resistant Enterococcus faecalis, extended-spectrum beta-lactamase-producing Klebsiella pneumoniae, carbapenem-resistant Acinetobacter baumannii, Acinetobacter baumannii susceptible only to carbapenems, and Pseudomonas aeruginosa susceptible to imipenem and meropenem. All isolates were completely inhibited by the ozone-oxygen mixture while growth occurred in the other 2 groups. CONCLUSION: A single topical application by nebulization of a low ozone dose completely inhibited the growth of all potentially pathogenic bacterial strains with known resistance to antimicrobial agents.


Subject(s)
Bacteria/drug effects , Disinfectants/pharmacology , Gases/pharmacology , Ozone/pharmacology , Microbial Viability/drug effects , Time Factors
7.
Ann Clin Microbiol Antimicrob ; 6: 8, 2007 Aug 15.
Article in English | MEDLINE | ID: mdl-17697363

ABSTRACT

BACKGROUND: Considering the increasing use of polymyxins to treat infections due to multidrug resistant Gram-negative in many countries, it is important to evaluate different susceptibility testing methods to this class of antibiotic. METHODS: Susceptibility of 109 carbapenem-resistant P. aeruginosa to polymyxins was tested comparing broth microdilution (reference method), disc diffusion, and Etest using the new interpretative breakpoints of Clinical and Laboratory Standards Institute. RESULTS: Twenty-nine percent of isolates belonged to endemic clone and thus, these strains were excluded of analysis. Among 78 strains evaluated, only one isolate was resistant to polymyxin B by the reference method (MIC: 8.0 microg/mL). Very major and major error rates of 1.2% and 11.5% were detected comparing polymyxin B disc diffusion with the broth microdilution (reference method). Agreement within 1 twofold dilution between Etest and the broth microdilution were 33% for polymyxin B and 79.5% for colistin. One major error and 48.7% minor errors were found comparing polymyxin B Etest with broth microdilution and only 6.4% minor errors with colistin. The concordance between Etest and the broth microdilution (reference method) was respectively 100% for colistin and 90% for polymyxin B. CONCLUSION: Resistance to polymyxins seems to be rare among hospital carbapenem-resistant P. aeruginosa isolates over a six-year period. Our results showed, using the new CLSI criteria, that the disc diffusion susceptibility does not report major errors (false-resistant results) for colistin. On the other hand, showed a high frequency of minor errors and 1 very major error for polymyxin B. Etest presented better results for colistin than polymyxin B. Until these results are reproduced with a large number of polymyxins-resistant P. aeruginosa isolates, susceptibility to polymyxins should be confirmed by a reference method.


Subject(s)
Anti-Bacterial Agents/pharmacology , Colistin/pharmacology , Microbial Sensitivity Tests/methods , Polymyxin B/pharmacology , Pseudomonas aeruginosa/drug effects , Carbapenems/pharmacology , Drug Resistance, Bacterial , False Positive Reactions , Humans , Pseudomonas Infections/microbiology
8.
Am J Infect Control ; 34(1): 36-40, 2006 Feb.
Article in English | MEDLINE | ID: mdl-16443091

ABSTRACT

BACKGROUND: Controversy surrounds the source (skin vs mucosa) of coagulase-negative staphylococci (CoNS) bacteremia in cancer patients. Determining the source of this infection has clinical and epidemiologic implications. OBJECTIVE: To determine the source(s) of CoNS bacteremia in cancer patients. METHODS: Between November 1998 and October 2000, cultures of nasal and rectal mucosa and skin at central venous catheter (CVC) sites were obtained in 62 patients (66 episodes) with CoNS-positive blood culture(s). Bacteremia was classified as true, indeterminate, or unlikely on the basis of clinical and microbiologic findings. Molecular relatedness of strains isolated from the blood and from colonized sites of patients with true and those with unlikely bacteremia was examined using pulsed-field gel electrophoresis (PFGE). RESULTS: CoNS colonization was present in 55 episodes (83%). The nasal mucosa was the most frequently colonized site (86%), followed by rectal mucosa (40%) and skin at site of CVC insertion (38%) (P < .001). Colonization at > or =1 site was common. True and unlikely bacteremia accounted for 11 and 10 episodes, respectively, with the remaining 45 episodes considered undetermined or had negative surveillance cultures. Among patients with true bacteremia, 6 mucosal isolates and only 1 skin isolate were related by PFGE to the blood isolate recovered from the same patient. CONCLUSION: Mucosa is the most common site of CoNS colonization and is the likely source of CoNS bacteremia in cancer patients.


Subject(s)
Bacteremia/microbiology , Neoplasms/complications , Staphylococcal Infections/microbiology , Staphylococcus/isolation & purification , Adult , Aged , Aged, 80 and over , Bacteremia/epidemiology , Blood/microbiology , DNA Fingerprinting , DNA, Bacterial/analysis , DNA, Bacterial/isolation & purification , Electrophoresis, Gel, Pulsed-Field , Female , Humans , Intestinal Mucosa/microbiology , Male , Middle Aged , Molecular Epidemiology , Nasal Mucosa/microbiology , Pilot Projects , Skin/microbiology , Staphylococcal Infections/complications , Staphylococcal Infections/epidemiology , Staphylococcus/classification , Staphylococcus/genetics
9.
Pediatr Infect Dis J ; 24(7): 648-50, 2005 Jul.
Article in English | MEDLINE | ID: mdl-15999012

ABSTRACT

Four cases of infection by extended spectrum beta-lactamase-producing Klebsiella pneumoniae occurred in the neonatal intensive care unit. Isolation, empiric therapy change and education produced no effect. Newborn weekly colonization rates were 0-18.7%. One health care worker with onychomycosis was positive for extended spectrum beta-lactamase-producing K. pneumoniae. Isolates were identical by molecular typing. Outbreak was controlled when the health care worker was excluded from the neonatal intensive care unit.


Subject(s)
Disease Outbreaks , Intensive Care Units, Neonatal , Klebsiella Infections/epidemiology , Klebsiella pneumoniae/enzymology , beta-Lactamases/metabolism , Adult , Aminoglycosides/pharmacology , Anti-Bacterial Agents/pharmacology , Cephalosporins/pharmacology , Cross Infection/epidemiology , Cross Infection/microbiology , Drug Resistance, Bacterial , Hand/microbiology , Hand Dermatoses/complications , Hand Dermatoses/microbiology , Health Personnel , Humans , Infant, Newborn , Klebsiella pneumoniae/drug effects , Klebsiella pneumoniae/isolation & purification , Onychomycosis/complications
10.
Infect Control Hosp Epidemiol ; 25(10): 868-72, 2004 Oct.
Article in English | MEDLINE | ID: mdl-15518031

ABSTRACT

OBJECTIVES: To evaluate the emergence of resistance of Pseudomonas aeruginosa and Acinetobacter species to imipenem, ciprofloxacin, or both after the use of these drugs and to compare resistant with susceptible isolates by molecular typing. DESIGN: Cohort study. SETTING: Burn intensive care unit (ICU) with 4 beds in a tertiary-care university hospital. METHODS: During 16 months, surveillance cultures were performed for all patients admitted to the ICU. Demographic information was obtained for each patient. Molecular typing was done by pulsed-field gel electrophoresis using restriction enzymes for 71 isolates of P. aeruginosa and Acinetobacter species. RESULTS: Thirty-four patients were admitted and 22 were colonized by susceptible P. aeruginosa or Acinetobacter species before they used the antimicrobials. Nine (41%) of these patients had a resistant isolate after antimicrobial use: 5 had used imipenem alone, 1 had used ciprofloxacin, and 3 had used both drugs. The interval between isolation of the susceptible and resistant isolates ranged from 4 to 25 days, but was 10 or more days for 6 patients. Molecular typing revealed that susceptible and resistant isolates from each patient were different and that although there were no predominant clones among susceptible isolates, there was a predominant clone among resistant isolates of P. aeruginosa and of Acinetobacter. CONCLUSIONS: Resistance was not due to the acquisition of resistance mechanisms by a previously susceptible strain, but rather to cross-transmission. Although various measures involving antimicrobial use have received great attention, it would seem that practices to prevent cross-transmission are more important in controlling resistance.


Subject(s)
Acinetobacter/drug effects , Anti-Bacterial Agents/pharmacology , Anti-Infective Agents/pharmacology , Burns/drug therapy , Ciprofloxacin/pharmacology , Drug Resistance, Bacterial , Imipenem/pharmacology , Pseudomonas aeruginosa/drug effects , Acinetobacter/isolation & purification , Adult , Anti-Bacterial Agents/therapeutic use , Anti-Infective Agents/therapeutic use , Ciprofloxacin/therapeutic use , Cohort Studies , Electrophoresis, Gel, Pulsed-Field , Female , Humans , Imipenem/therapeutic use , Intensive Care Units , Male , Pseudomonas aeruginosa/isolation & purification
SELECTION OF CITATIONS
SEARCH DETAIL
...